Cancer

Exact Sciences gets FDA approval for next-gen Cologuard Plus test
By LabPulse.com staff writers
Exact Sciences has received U.S. Food and Drug Administration (FDA) approval for its next-generation Cologuard Plus colorectal cancer (CRC) screening test.
October 7, 2024
Fda Sign Dc Social
Geneoscopy adds N.Y. state lab permit for wider ColoSense testing
By LabPulse.com staff writers
Noninvasive colorectal cancer screening test developer Geneoscopy has received a laboratory permit from the New York State Department of Health.
October 1, 2024
Colorectal Cancer Social (1)
Ibex survey indicates some comfort with AI in cancer diagnostics
By LabPulse.com staff writers
A recent survey reports that more than 50% of U.S. adults have received an incorrect medical test result for themselves or a loved one. Additionally, 60% would trust artificial intelligence (AI) supporting medical diagnoses.
September 25, 2024
Doctor Patient Consult
Scancell, PharmaJet sign agreement for melanoma vaccine delivery system
By LabPulse.com staff writers
Clinical-stage biopharmaceutical company Scancell has signed a strategic partnership agreement with PharmaJet for the supply of PharmaJet's needle-free Stratis delivery system for the delivery of Scancell's advanced melanoma vaccine.
September 18, 2024
Business Agreement Social
AI model shows promise for 'virtual staining' of cancerous tissue
By LabPulse.com staff writers
Researchers have created an artificial intelligence (AI) model that generates images showing virtual colorations of cancerous tissue.
September 12, 2024
Pathology Digital Workstation Microscope Social
A. Menarini, Nucleix sign distribution agreement for bladder cancer test
By LabPulse.com staff writers
A. Menarini Diagnostics and liquid biopsy firm Nucleix have signed a strategic partnership for the exclusive distribution of Nucleix's Bladder EpiCheck test.
September 9, 2024
Bladder Urinary 3 D Social
Hitachi High-Tech, Gencurix forge agreement on cancer diagnostics
By LabPulse.com staff writers
Hitachi High-Tech and oncology molecular diagnostics firm Gencurix have formed a strategic partnership aimed at developing cancer diagnostics and testing services.
August 30, 2024
Hands Shaking2 Social
Upcoming lung cancer molecular testing guidelines address 7 questions
By Liz Carey
Revised guideline addresses next-generation sequencing and expanded biomarker testing.
August 28, 2024
Lung Cancer Hotspot Social
University of Eastern Finland researchers develop algorithm for better breast cancer screening
By LabPulse.com staff writers
Researchers at the University of Eastern Finland have developed an algorithm to improve mammogram density assessment, with the potential to increase screening accuracy.
August 23, 2024
Breast Mammo Social
Alpenglow Biosciences lands $24M for 3D pathology platform
By LabPulse.com staff writers
Company gets boost to commercialize direct-to-digital pathology platform and AI.
August 15, 2024
Money Hundred Bills Social
Study: Symptom-triggered testing effective for ovarian cancer diagnosis
By LabPulse.com staff writers
The results of a new U.K. study showed that testing prompted by symptoms can pick up aggressive, early-stage ovarian cancer in 1 in 4 affected patients.
August 13, 2024
Ovarian Cancer2 Social
Halda Therapeutics raises $126M to advance candidates to clinical trials
By LabPulse.com staff writers
Biotech firm Halda Therapeutics has raised $126 million in financing from a series B extension, bringing its funding total to $202 million to date.
August 12, 2024
Money Hundred Bills Social
Page 1 of 98
Next Page